Form 4: Yao Zhengbin Acquires Alumis Inc. Stock

Yao Zhengbin, a Director at Alumis Inc., reported the acquisition of 3,553 shares of common stock and the grant of stock options for 15,528 shares.

Summary

• Yao Zhengbin, a Director of Alumis Inc. (ALMS), has acquired 3,553 shares of common stock.
• These shares were acquired as part of a Restricted Stock Unit (RSU) grant.
• Additionally, Mr. Zhengbin was granted stock options to purchase 15,528 shares of common stock.
• The RSU shares vest on the first anniversary of the grant date or by the Issuer's 2027 annual stockholder meeting, whichever comes first, contingent on continued service.
• The stock options vest under similar conditions, with full vesting upon a Change in Control, subject to continued service.
• The transaction date for these events was June 30, 2026.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it involves standard insider equity grants and acquisitions that align management with long-term company performance, without indicating immediate significant positive or negative news.

Positives

• Director acquisition of company stock can signal confidence in the company's future prospects.
• Granting of stock options aligns management incentives with shareholder value creation.
• Vesting schedules tied to performance or time encourage long-term commitment.

Risks

• Vesting of RSUs and stock options is contingent on continued service, meaning departure from the company could result in forfeiture.
• Vesting is also subject to the Issuer's 2027 annual stockholder meeting, indicating a multi-year vesting period.
• A Change in Control clause for full vesting could imply potential future strategic shifts or acquisition possibilities.

Future Outlook

The vesting schedules for both the RSUs and stock options indicate a multi-year outlook, with full vesting by the 2027 annual stockholder meeting or upon a Change in Control. The stock options have an expiration date of June 29, 2036.

Industry Context

StockSavvy.ai notes that insider transactions, such as director stock acquisitions and option grants, are common in the biotechnology and pharmaceutical sectors where Alumis Inc. operates. These actions often reflect management's long-term view on the company's pipeline and market potential.

Stakeholder Impact

• Shareholders: The acquisition of stock by a director can be seen as a positive signal of confidence, potentially influencing investor sentiment.
• Employees: The vesting conditions for RSUs and options highlight the importance of continued employment and performance.
• Management: The equity grants align the reporting person's financial interests with those of the company and its shareholders.

Next Steps

• Continued service by Yao Zhengbin to meet vesting requirements for RSUs and stock options.
• Monitoring of Alumis Inc.'s progress towards the 2027 annual stockholder meeting for full vesting.
• Observation of any potential Change in Control events that could trigger immediate vesting.

Key Dates

Keywords

Alumis Inc., ALMS, Form 4, Insider Trading, Stock Options, Restricted Stock Units, Director, Beneficial Ownership, SEC Filing